(BLX) Foreign Trade Bank of Latin - Ratings and Ratios
Trade Finance, Export Lending, Import Credit, Asset Secured
BLX EPS (Earnings per Share)
BLX Revenue
Description: BLX Foreign Trade Bank of Latin August 13, 2025
Foreign Trade Bank of Latin America Inc (BLX) is a Panamanian common stock operating in the Specialized Finance sub-industry. The bank provides financial services to Latin American countries, facilitating international trade.
To evaluate BLXs performance, key metrics include Return on Equity (RoE) of 15.63%, indicating the banks ability to generate profits from shareholders equity. The Price-to-Earnings (P/E) ratio of 7.02 suggests that the stock is undervalued relative to its earnings. Market capitalization stands at $1.446 billion, reflecting the companys size and investor confidence.
Economic drivers influencing BLXs performance include Latin Americas trade dynamics, regional economic growth, and the banks ability to navigate complex financial transactions. Key Performance Indicators (KPIs) to monitor include net interest margin, loan growth, and asset quality. The banks exposure to emerging markets and trade finance opportunities positions it for potential growth, driven by increasing demand for financial services in the region.
Investors should consider the banks competitive positioning, risk management practices, and regulatory environment. BLXs beta of 0.84 indicates relatively lower volatility compared to the broader market. The stocks current price is near its 52-week high, suggesting strong recent performance. Average trading volume is around 131,150 shares, indicating moderate liquidity.
BLX Stock Overview
| Market Cap in USD | 1,683m |
| Sub-Industry | Specialized Finance |
| IPO / Inception | 1992-09-24 |
BLX Stock Ratings
| Growth Rating | 96.3% |
| Fundamental | 55.0% |
| Dividend Rating | 83.9% |
| Return 12m vs S&P 500 | 20.3% |
| Analyst Rating | 4.50 of 5 |
BLX Dividends
| Dividend Yield 12m | 5.29% |
| Yield on Cost 5y | 25.29% |
| Annual Growth 5y | 15.21% |
| Payout Consistency | 81.9% |
| Payout Ratio | 39.8% |
BLX Growth Ratios
| Growth Correlation 3m | 15.5% |
| Growth Correlation 12m | 94.3% |
| Growth Correlation 5y | 94% |
| CAGR 5y | 50.77% |
| CAGR/Max DD 3y (Calmar Ratio) | 2.42 |
| CAGR/Mean DD 3y (Pain Ratio) | 12.93 |
| Sharpe Ratio 12m | 1.28 |
| Alpha | 27.99 |
| Beta | 0.871 |
| Volatility | 23.38% |
| Current Volume | 149.9k |
| Average Volume 20d | 124.8k |
| Stop Loss | 43.5 (-3.1%) |
| Signal | -0.27 |
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (220.4m TTM) > 0 and > 6% of Revenue (6% = 49.1m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 1.77pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -711.9% (prev -12.26%; Δ -699.7pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.01 (>3.0%) and CFO 143.3m <= Net Income 220.4m (YES >=105%, WARN >=100%) |
| Net Debt (2.02b) to EBITDA (224.4m) ratio: 9.01 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (36.9m) change vs 12m ago 0.45% (target <= -2.0% for YES) |
| Gross Margin 35.60% (prev 50.49%; Δ -14.90pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 6.94% (prev 7.43%; Δ -0.49pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.43 (EBITDA TTM 224.4m / Interest Expense TTM 513.4m) >= 6 (WARN >= 3) |
Altman Z'' -2.54
| (A) -0.46 = (Total Current Assets 2.18b - Total Current Liabilities 8.01b) / Total Assets 12.67b |
| (B) 0.07 = Retained Earnings (Balance) 861.4m / Total Assets 12.67b |
| (C) 0.02 = EBIT TTM 220.4m / Avg Total Assets 11.79b |
| (D) 0.12 = Book Value of Equity 1.39b / Total Liabilities 11.26b |
| Total Rating: -2.54 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 55.03
| 1. Piotroski 2.0pt = -3.0 |
| 2. FCF Yield 3.88% = 1.94 |
| 3. FCF Margin 17.12% = 4.28 |
| 4. Debt/Equity 2.82 = -0.50 |
| 5. Debt/Ebitda 9.01 = -2.50 |
| 6. ROIC - WACC (= -1.20)% = -1.50 |
| 7. RoE 16.23% = 1.35 |
| 8. Rev. Trend 71.81% = 5.39 |
| 9. EPS Trend -8.42% = -0.42 |
What is the price of BLX shares?
Over the past week, the price has changed by -0.80%, over one month by -3.03%, over three months by +11.89% and over the past year by +43.98%.
Is Foreign Trade Bank of Latin a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BLX is around 63.62 USD . This means that BLX is currently undervalued and has a potential upside of +41.76% (Margin of Safety).
Is BLX a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BLX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 55.5 | 23.7% |
| Analysts Target Price | 55.5 | 23.7% |
| ValueRay Target Price | 68.4 | 52.4% |
BLX Fundamental Data Overview October 28, 2025
P/E Trailing = 7.5779
P/S = 5.4976
P/B = 1.1836
P/EG = 1.58
Beta = 0.871
Revenue TTM = 818.5m USD
EBIT TTM = 220.4m USD
EBITDA TTM = 224.4m USD
Long Term Debt = 2.54b USD (from longTermDebt, last quarter)
Short Term Debt = 1.44b USD (from shortTermDebt, last quarter)
Debt = 3.99b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.02b USD (from netDebt column, last quarter)
Enterprise Value = 3.61b USD (1.68b + Debt 3.99b - CCE 2.07b)
Interest Coverage Ratio = 0.43 (Ebit TTM 220.4m / Interest Expense TTM 513.4m)
FCF Yield = 3.88% (FCF TTM 140.1m / Enterprise Value 3.61b)
FCF Margin = 17.12% (FCF TTM 140.1m / Revenue TTM 818.5m)
Net Margin = 26.93% (Net Income TTM 220.4m / Revenue TTM 818.5m)
Gross Margin = 35.60% ((Revenue TTM 818.5m - Cost of Revenue TTM 527.2m) / Revenue TTM)
Gross Margin QoQ = 39.23% (prev 35.99%)
Tobins Q-Ratio = 0.28 (Enterprise Value 3.61b / Total Assets 12.67b)
Interest Expense / Debt = 3.17% (Interest Expense 126.7m / Debt 3.99b)
Taxrate = 21.0% (US default 21%)
NOPAT = 174.1m (EBIT 220.4m * (1 - 21.00%))
Current Ratio = 0.27 (Total Current Assets 2.18b / Total Current Liabilities 8.01b)
Debt / Equity = 2.82 (Debt 3.99b / totalStockholderEquity, last quarter 1.42b)
Debt / EBITDA = 9.01 (Net Debt 2.02b / EBITDA 224.4m)
Debt / FCF = 14.43 (Net Debt 2.02b / FCF TTM 140.1m)
Total Stockholder Equity = 1.36b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.74% (Net Income 220.4m / Total Assets 12.67b)
RoE = 16.23% (Net Income TTM 220.4m / Total Stockholder Equity 1.36b)
RoCE = 5.65% (EBIT 220.4m / Capital Employed (Equity 1.36b + L.T.Debt 2.54b))
RoIC = 3.29% (NOPAT 174.1m / Invested Capital 5.29b)
WACC = 4.50% (E(1.68b)/V(5.68b) * Re(9.22%) + D(3.99b)/V(5.68b) * Rd(3.17%) * (1-Tc(0.21)))
Discount Rate = 9.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.55%
[DCF Debug] Terminal Value 65.32% ; FCFE base≈140.1m ; Y1≈92.0m ; Y5≈42.1m
Fair Price DCF = 23.88 (DCF Value 686.1m / Shares Outstanding 28.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -8.42 | EPS CAGR: -51.84% | SUE: 0.0 | # QB: 0
Revenue Correlation: 71.81 | Revenue CAGR: 33.05% | SUE: 4.0 | # QB: 9
Additional Sources for BLX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle